HARTFORD GREAT HEALTH CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6001 USD | -39.99% |
|
-.--% | -31.81% |
| Mar. 19 | Hartford Great Health Corp. Announces CEO Changes, Effective April 1, 2024 | CI |
| Mar. 19 | Hartford Great Health Corp. Announces CFO Changes, Effective April 1, 2024 | CI |
Valuation
| Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 4.527 | 148.7 | 118.9 | 21.02 | 15.62 | 88.1 |
| Enterprise Value (EV) 1 | 4.526 | 149.3 | 123.9 | 26.46 | 15.89 | 88.51 |
| P/E ratio | -178 x | -158 x | -44.9 x | -9.3 x | -9.89 x | 222 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | 2,646,455,656 x | 1,209,777,534 x | 37,984,169 x | 27,824,524 x | - |
| EV / Revenue | - | 2,658,053,904 x | 1,260,188,979 x | 47,816,908 x | 28,314,089 x | - |
| EV / EBITDA | -261 x | -221 x | -68 x | -9.25 x | -9.07 x | -759 x |
| EV / FCF | -370 x | -1,050 x | 152 x | 48.9 x | -15.6 x | -40.8 x |
| FCF Yield | -0.27% | -0.1% | 0.66% | 2.04% | -6.4% | -2.45% |
| Price to Book | 7,426 x | 112 x | -86.8 x | -5.56 x | -3.04 x | -19.6 x |
| Nbr of stocks (in thousands) | 3,018 | 99,108 | 99,108 | 100,108 | 100,108 | 100,108 |
| Reference price 2 | 1.500 | 1.500 | 1.200 | 0.2100 | 0.1560 | 0.8800 |
| Announcement Date | 11/14/18 | 11/14/19 | 11/10/20 | 10/29/21 | 11/14/22 | 10/30/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales | - | 0.0562 | 0.0983 | 0.5535 | 0.5613 | - |
| EBITDA 1 | -0.0173 | -0.6761 | -1.822 | -2.861 | -1.752 | -0.1167 |
| EBIT 1 | -0.0179 | -0.6825 | -1.871 | -2.946 | -1.874 | -0.1236 |
| Operating Margin | - | -1,215.01% | -1,902.87% | -532.26% | -333.83% | - |
| Earnings before Tax (EBT) 1 | -0.0254 | -0.66 | -3.654 | -2.842 | -1.772 | 0.3977 |
| Net income 1 | -0.0254 | -0.5842 | -2.651 | -2.253 | -1.579 | 0.3969 |
| Net margin | - | -1,039.93% | -2,697.03% | -407.14% | -281.35% | - |
| EPS 2 | -0.008404 | -0.009504 | -0.0268 | -0.0226 | -0.0158 | 0.003964 |
| Free Cash Flow 1 | -0.0122 | -0.1422 | 0.8149 | 0.5407 | -1.018 | -2.169 |
| FCF margin | - | -253.19% | 828.98% | 97.69% | -181.31% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 11/14/18 | 11/14/19 | 11/10/20 | 10/29/21 | 11/14/22 | 10/30/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 0.65 | 4.96 | 5.44 | 0.27 | 0.41 |
| Net Cash position 1 | 0 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -0.9636 x | -2.72 x | -1.902 x | -0.1569 x | -3.529 x |
| Free Cash Flow 1 | -0.01 | -0.14 | 0.81 | 0.54 | -1.02 | -2.17 |
| ROE (net income / shareholders' equity) | 247% | -106% | 704% | 78.2% | 31% | -7.27% |
| ROA (Net income/ Total Assets) | -572% | -23.2% | -23.5% | -30.6% | -22.8% | -3.4% |
| Assets 1 | 0.004434 | 2.517 | 11.3 | 7.363 | 6.932 | -11.67 |
| Book Value Per Share 2 | 0 | 0.0100 | -0.0100 | -0.0400 | -0.0500 | -0.0400 |
| Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capex | - | 0 | 0.27 | 0.17 | 0.15 | - |
| Capex / Sales | - | 6.57% | 275.47% | 30.41% | 25.84% | - |
| Announcement Date | 11/14/18 | 11/14/19 | 11/10/20 | 10/29/21 | 11/14/22 | 10/30/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -31.81% | 60.07M | |
| +6.63% | 68.68B | |
| +14.27% | 52.03B | |
| +11.28% | 16.01B | |
| +16.71% | 15.4B | |
| +19.80% | 11.05B | |
| +24.01% | 9.26B | |
| +11.86% | 5.09B | |
| +4.83% | 4.37B | |
| +19.66% | 3.71B |
- Stock Market
- Equities
- HFUS Stock
- Financials Hartford Great Health Corp.
